114 related articles for article (PubMed ID: 8780035)
21. A beta-amino acid modified heptapeptide containing a designed recognition element disrupts fibrillization of the amyloid beta-peptide.
Castelletto V; Hamley IW; Lim T; De Tullio MB; Castaño EM
J Pept Sci; 2010 Sep; 16(9):443-50. PubMed ID: 20648477
[TBL] [Abstract][Full Text] [Related]
22. Alzheimer's disease amyloid beta-protein forms Zn(2+)-sensitive, cation-selective channels across excised membrane patches from hypothalamic neurons.
Kawahara M; Arispe N; Kuroda Y; Rojas E
Biophys J; 1997 Jul; 73(1):67-75. PubMed ID: 9199772
[TBL] [Abstract][Full Text] [Related]
23. Transformation of beta-amyloid (A beta) (1-42) tyrosine to L-dopa as the result of in vitro hydroxyl radical attack.
Giunta S; Ronchi P; Valli B; Franceschi C; Galeazzi L
Amyloid; 2000 Sep; 7(3):189-93. PubMed ID: 11019859
[TBL] [Abstract][Full Text] [Related]
24. Charge states rather than propensity for beta-structure determine enhanced fibrillogenesis in wild-type Alzheimer's beta-amyloid peptide compared to E22Q Dutch mutant.
Massi F; Klimov D; Thirumalai D; Straub JE
Protein Sci; 2002 Jul; 11(7):1639-47. PubMed ID: 12070316
[TBL] [Abstract][Full Text] [Related]
25. Alpha2-macroglobulin attenuates beta-amyloid peptide 1-40 fibril formation and associated neurotoxicity of cultured fetal rat cortical neurons.
Du Y; Bales KR; Dodel RC; Liu X; Glinn MA; Horn JW; Little SP; Paul SM
J Neurochem; 1998 Mar; 70(3):1182-8. PubMed ID: 9489740
[TBL] [Abstract][Full Text] [Related]
26. Cross-linking of a synthetic partial-length (1-28) peptide of the Alzheimer beta/A4 amyloid protein by transglutaminase.
Ikura K; Takahata K; Sasaki R
FEBS Lett; 1993 Jul; 326(1-3):109-11. PubMed ID: 8100780
[TBL] [Abstract][Full Text] [Related]
27. Amyloidogenicity and neurotoxicity of peptides corresponding to the helical regions of PrP(C).
Thompson A; White AR; McLean C; Masters CL; Cappai R; Barrow CJ
J Neurosci Res; 2000 Oct; 62(2):293-301. PubMed ID: 11020222
[TBL] [Abstract][Full Text] [Related]
28. A synchrotron-based hydroxyl radical footprinting analysis of amyloid fibrils and prefibrillar intermediates with residue-specific resolution.
Klinger AL; Kiselar J; Ilchenko S; Komatsu H; Chance MR; Axelsen PH
Biochemistry; 2014 Dec; 53(49):7724-34. PubMed ID: 25382225
[TBL] [Abstract][Full Text] [Related]
29. Effect of acid predissolution on fibril size and fibril flexibility of synthetic beta-amyloid peptide.
Shen CL; Fitzgerald MC; Murphy RM
Biophys J; 1994 Sep; 67(3):1238-46. PubMed ID: 7811938
[TBL] [Abstract][Full Text] [Related]
30. Glutamine synthetase, hemoglobin alpha-chain, and macrophage migration inhibitory factor binding to amyloid beta-protein: their identification in rat brain by a novel affinity chromatography and in Alzheimer's disease brain by immunoprecipitation.
Oyama R; Yamamoto H; Titani K
Biochim Biophys Acta; 2000 Jun; 1479(1-2):91-102. PubMed ID: 11004532
[TBL] [Abstract][Full Text] [Related]
31. Oxidatively induced structural alteration of glutamine synthetase assessed by analysis of spin label incorporation kinetics: relevance to Alzheimer's disease.
Butterfield DA; Hensley K; Cole P; Subramaniam R; Aksenov M; Aksenova M; Bummer PM; Haley BE; Carney JM
J Neurochem; 1997 Jun; 68(6):2451-7. PubMed ID: 9166739
[TBL] [Abstract][Full Text] [Related]
32. Amidation of beta-amyloid peptide strongly reduced the amyloidogenic activity without alteration of the neurotoxicity.
Forloni G; Lucca E; Angeretti N; Della Torre P; Salmona M
J Neurochem; 1997 Nov; 69(5):2048-54. PubMed ID: 9349550
[TBL] [Abstract][Full Text] [Related]
33. Evidence of fibril-like β-sheet structures in a neurotoxic amyloid intermediate of Alzheimer's β-amyloid.
Chimon S; Shaibat MA; Jones CR; Calero DC; Aizezi B; Ishii Y
Nat Struct Mol Biol; 2007 Dec; 14(12):1157-64. PubMed ID: 18059284
[TBL] [Abstract][Full Text] [Related]
34. Amyloid beta peptide (25-35) inhibits Na+-dependent glutamate uptake in rat hippocampal astrocyte cultures.
Harris ME; Wang Y; Pedigo NW; Hensley K; Butterfield DA; Carney JM
J Neurochem; 1996 Jul; 67(1):277-86. PubMed ID: 8667003
[TBL] [Abstract][Full Text] [Related]
35. In vitro peroxidase oxidation induces stable dimers of beta-amyloid (1-42) through dityrosine bridge formation.
Galeazzi L; Ronchi P; Franceschi C; Giunta S
Amyloid; 1999 Mar; 6(1):7-13. PubMed ID: 10211406
[TBL] [Abstract][Full Text] [Related]
36. Heparan sulfate and chondroitin sulfate glycosaminoglycan attenuate beta-amyloid(25-35) induced neurodegeneration in cultured hippocampal neurons.
Woods AG; Cribbs DH; Whittemore ER; Cotman CW
Brain Res; 1995 Oct; 697(1-2):53-62. PubMed ID: 8593595
[TBL] [Abstract][Full Text] [Related]
37. Structure-activity analyses of beta-amyloid peptides: contributions of the beta 25-35 region to aggregation and neurotoxicity.
Pike CJ; Walencewicz-Wasserman AJ; Kosmoski J; Cribbs DH; Glabe CG; Cotman CW
J Neurochem; 1995 Jan; 64(1):253-65. PubMed ID: 7798921
[TBL] [Abstract][Full Text] [Related]
38. Laminin inhibition of beta-amyloid protein (Abeta) fibrillogenesis and identification of an Abeta binding site localized to the globular domain repeats on the laminin a chain.
Castillo GM; Lukito W; Peskind E; Raskind M; Kirschner DA; Yee AG; Snow AD
J Neurosci Res; 2000 Nov; 62(3):451-62. PubMed ID: 11054814
[TBL] [Abstract][Full Text] [Related]
39. Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state.
Pike CJ; Burdick D; Walencewicz AJ; Glabe CG; Cotman CW
J Neurosci; 1993 Apr; 13(4):1676-87. PubMed ID: 8463843
[TBL] [Abstract][Full Text] [Related]
40. Amyloid beta protein forms ion channels: implications for Alzheimer's disease pathophysiology.
Lin H; Bhatia R; Lal R
FASEB J; 2001 Nov; 15(13):2433-44. PubMed ID: 11689468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
